Sherita A King
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Sherita A King has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Luke Scanlan
Medical College of Georgia at Augusta University , Augusta, Georgia , United States
1 shared publication - Martha K. Terris
Medical College of Georgia, Department of Urology, 1447 Harper Street, Augusta, GA, 30912, United States of America
1 shared publication - Matthew N. Simmons
Medical College of Georgia at Augusta University , Augusta, Georgia , United States
1 shared publication - Om V. Sakhalkar
Augusta Univ, Med Coll Georgia, Dept Urol, Augusta, GA USA
1 shared publication - Pablo J. SantaMaria
The Medical College of Georgia, Augusta University, Augusta, GA 30912, USA
1 shared publication - Zachary Klaassen
Medical College of Georgia at Augusta University , Augusta, Georgia , United States
1 shared publication
Latest Publications
- Open Access
- 3 February 2024
- Published by Oxford University Press (OUP) in Journal of Surgical Case Reports
- Vol. 2024 (2) , rjae064
Transgender patient undergoing Rezum therapy: a case report
Rezūm is a relatively new, minimally invasive approach that utilizes vaporized water to ablate prostatic tissue surrounding the proximal urethra in patients with benign prostatic hyperplasia. However, of the many notable studies involving Rezūm’s effectiveness in men, none have documented use of Rezūm in the transgender community. With a growing population of transgender patients in the USA, prostate treatments will be offered for transgender women on a more regular basis. To the best of our knowledge, we introduce the first case of Rezūm being utilized to treat benign prostatic hyperplasia in a patient self-identifying as a woman.
- 3 February 2024
- Published by Oxford University Press (OUP) in Journal of Surgical Case Reports
- Vol. 2024 (2) , rjae064
Open AccessTransgender patient undergoing Rezum therapy: a case report
Rezūm is a relatively new, minimally invasive approach that utilizes vaporized water to ablate prostatic tissue surrounding the proximal urethra in patients with benign prostatic hyperplasia. However, of the many notable studies involving Rezūm’s effectiveness in men, none have documented use of Rezūm in the transgender community. With a growing population of transgender patients in the USA, prostate treatments will be offered for transgender women on a more regular basis. To the best of our knowledge, we introduce the first case of Rezūm being utilized to treat benign prostatic hyperplasia in a patient self-identifying as a woman.